Company Name
Oramed Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US68403P2039
CIK:
0001176309
CUSIP:
68403P104
Currency:
USD
Full Time Employees:
0
Phone:
844 967 2633
Website:
https://oramed.com
Fiscal Year End:
December
IPO Date:
Apr 21, 2006
Description:
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Address:
1185 Avenue of the Americas, New York, NY, United States, 10036